SLRX Salarius Pharmaceuticals, Inc.: Company Short-Term Debts
Salarius Pharmaceuticals (SLRX) develops advanced genetic therapies to combat severe oncological pathologies across various age groups. This chart of stock quotes complements the business data, where the indicator stands at 0.00. Patent protection minimizes price wars, leaving risks solely to the scientific discoveries of competitors. However, a critical liquidity shortage and previous FDA regulatory delays pose a threat of company closure.
SLRX (Salarius Pharma): analytical breakdowns and indicator data
- stock price and consensus target price:
- company stock capitalization data:
- business book valuation details:
- debt and liquidity details:
Total Debt to Capital Salarius Pharmaceuticals|SLRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Salarius Pharmaceuticals|SLRX - Company Aggregate Debts|Debt to Book Capitalization Ratio Salarius Pharmaceuticals, Inc.|SLRX - Company Long-Term Loans and Borrowings|Company Short-Term Debts Salarius Pharmaceuticals|Quick Liquidity salariuspharma.com
- earnings and multiples data:
Analysis of all company metrics:SLRX - Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals focuses on developing precision epigenetic drugs to combat rare sarcomas and pediatric oncology. The dynamics of short-term liabilities reflect the total obligations maturing within one year, allowing investors to assess current liquidity and the risk of capital shortages when funding costly clinical trials, independent of market noise.
Competing companies
BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|Short-Term Debt Volume tuhurabio.com|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Company Short-Term Debts Fate Therapeutics Inc FATE|WHWK - Company Short-Term Debt|TCRX: Company Short-Term Debt|CSBR: Company Short-Term Debts|XBiotech (XBIT) - Company Short-Term Debts|Company Short-Term Debt CEL-SCI Corp.|OSTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts RADX|Short-Term Debt Volume artivabio.com|Adlai Nortye - Company Current Liabilities|Company Short-Term Debts verupharma.com VERU|TPST - Company Short-Term Debt|Short-Term Debt Volume Xilio Therapeutics, Inc. XLO|RENB (renovarobio.com) - Company Current Liabilities|Mural Oncology - Company Short-Term Loans and Borrowings|Company Short-Term Debt Kairos Pharma Limited|OnKure - Current Liabilities|Company Short-Term Debts GDTC|CRIS (curis.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts APLM (Apollomics)|Company Short-Term Debts Tharimmune Corporation THAR|ADVB - Company Short-Term Debt|Company Short-Term Loans and Borrowings GNPX (genprex.com)|calidibio.com (CLDI) - Company Short-Term Debt|Company Current Liabilities sunshinebiopharma.com|XBIO (Xenetic Biosciences Inc.) - Company Short-Term Debts|Company Short-Term Debts Kitov Pharma|Company Short-Term Debts AONC|Company Current Liabilities beigene.com BGNE|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Elevation Oncology Inc. (ELEV) - Short-Term Debt|ICAD: Company Current Liabilities|IKNA - Company Short-Term Debts|NTBL (Notable Labs, Ltd.) - Company Current Liabilities|VIRX: Amount of Current Liabilities|MOR (MorphoSys) - Company Short-Term Debts|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Short-Term Debts AAPGV